361 related articles for article (PubMed ID: 20189848)
1. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
[TBL] [Abstract][Full Text] [Related]
2. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
3. [Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].
Yu T; Zhu SX; Zheng S; Chen SP
Zhonghua Nan Ke Xue; 2007 Mar; 13(3):222-5. PubMed ID: 17393784
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
5. The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins.
Daoud NA; Li G; Evans AJ; van der Kwast TH
J Clin Pathol; 2012 May; 65(5):437-40. PubMed ID: 22294716
[TBL] [Abstract][Full Text] [Related]
6. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
Stewart J; Fleshner N; Cole H; Sweet J
J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
[TBL] [Abstract][Full Text] [Related]
7. Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study.
Ng VW; Koh M; Tan SY; Tan PH
Am J Clin Pathol; 2007 Feb; 127(2):248-53. PubMed ID: 17210521
[TBL] [Abstract][Full Text] [Related]
8. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
Epstein JI; Egevad L; Humphrey PA; Montironi R;
Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
Shah RB; Kunju LP; Shen R; LeBlanc M; Zhou M; Rubin MA
Am J Clin Pathol; 2004 Oct; 122(4):517-23. PubMed ID: 15487448
[TBL] [Abstract][Full Text] [Related]
10. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
Jiang Z; Li C; Fischer A; Dresser K; Woda BA
Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047
[TBL] [Abstract][Full Text] [Related]
11. 34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts.
Pierconti F; Rossi ED; Martini M; Sacco E; Bassi PF; Larocca LM
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):306-310. PubMed ID: 29346181
[TBL] [Abstract][Full Text] [Related]
12. Is there a role for fatty acid synthase in the diagnosis of prostatic adenocarcinoma?: A comparison with AMACR.
Wu X; Zayzafoon M; Zhang X; Hameed O
Am J Clin Pathol; 2011 Aug; 136(2):239-46. PubMed ID: 21757596
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
[TBL] [Abstract][Full Text] [Related]
14. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
Ali TZ; Epstein JI
Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 34betaE12 and P63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies.
Wu HH; Lapkus O; Corbin M
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):285-9. PubMed ID: 15536326
[TBL] [Abstract][Full Text] [Related]
16. [The value of using an AMACR/34betaE12/p63 cocktail double staining for diagnosis of prostate carcinoma and precarcinomatous lesions].
Liu YN; Jiang ZM; Wang XY; Zhang HZ; Chen JQ; Huang J; Yang QH
Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):417-20. PubMed ID: 17069678
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
Kunju LP; Mehra R; Snyder M; Shah RB
Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
[TBL] [Abstract][Full Text] [Related]
18. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma.
Skinnider BF; Oliva E; Young RH; Amin MB
Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661
[TBL] [Abstract][Full Text] [Related]
19. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
Adley BP; Yang XJ
Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
[TBL] [Abstract][Full Text] [Related]
20. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]